临床研究中最小临床意义变化值(MCID)确定方法

2012-12-13 MedSci MedSci原创

目前确定最小临床意义变化值(minimal clinically important difference,MCID)的方法有效标法、分布法、专家意见法和文献分析法。效标法可对所确定的最小临床意义变化值给出专业解释,但没有考虑测量误差, 不同效标会产生不同的最小临床意义变化值,而且通常情况下很难找到合适的效标。分布法考虑了测量误差,易于实施,但不同样本得出的结果可能不同,无法为所 确定的最小可

目前确定最小临床意义变化值(minimal clinically important difference,MCID)的方法有效标法、分布法、专家意见法和文献分析法。效标法可对所确定的最小临床意义变化值给出专业解释,但没有考虑测量误差, 不同效标会产生不同的最小临床意义变化值,而且通常情况下很难找到合适的效标。分布法考虑了测量误差,易于实施,但不同样本得出的结果可能不同,无法为所 确定的最小可测变化值给出专业解释,对得出的最小可测变化值缺乏公认的判断准则。专家意见法和文献分析法则分别基于专家意见和已发表文献,只能作为辅助。 在确定最小临床意义变化值时,最好能综合使用效标法、分布法和专家意见法。全文下载: 临床研究中最小临床意义变化值(MCID)确定方法

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1991544, encodeId=178c199154475, content=<a href='/topic/show?id=f88a4e047f' target=_blank style='color:#2F92EE;'>#CID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4704, encryptionId=f88a4e047f, topicName=CID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 21 22:04:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5325, encodeId=a4385325d8, content=这个很不错,要是可以提供摘要就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ce75636, createdName=csjlsh, createdTime=Mon Jan 07 19:12:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519378, encodeId=8f0715193e8d4, content=<a href='/topic/show?id=3731113e8c3' target=_blank style='color:#2F92EE;'>#MCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11378, encryptionId=3731113e8c3, topicName=MCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=934111256894, createdName=hukaixun, createdTime=Sat Dec 15 09:04:00 CST 2012, time=2012-12-15, status=1, ipAttribution=)]
    2013-02-21 xlxchina
  2. [GetPortalCommentsPageByObjectIdResponse(id=1991544, encodeId=178c199154475, content=<a href='/topic/show?id=f88a4e047f' target=_blank style='color:#2F92EE;'>#CID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4704, encryptionId=f88a4e047f, topicName=CID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 21 22:04:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5325, encodeId=a4385325d8, content=这个很不错,要是可以提供摘要就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ce75636, createdName=csjlsh, createdTime=Mon Jan 07 19:12:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519378, encodeId=8f0715193e8d4, content=<a href='/topic/show?id=3731113e8c3' target=_blank style='color:#2F92EE;'>#MCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11378, encryptionId=3731113e8c3, topicName=MCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=934111256894, createdName=hukaixun, createdTime=Sat Dec 15 09:04:00 CST 2012, time=2012-12-15, status=1, ipAttribution=)]
    2013-01-07 csjlsh

    这个很不错,要是可以提供摘要就更好了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1991544, encodeId=178c199154475, content=<a href='/topic/show?id=f88a4e047f' target=_blank style='color:#2F92EE;'>#CID#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4704, encryptionId=f88a4e047f, topicName=CID)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 21 22:04:00 CST 2013, time=2013-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5325, encodeId=a4385325d8, content=这个很不错,要是可以提供摘要就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ce75636, createdName=csjlsh, createdTime=Mon Jan 07 19:12:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519378, encodeId=8f0715193e8d4, content=<a href='/topic/show?id=3731113e8c3' target=_blank style='color:#2F92EE;'>#MCI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11378, encryptionId=3731113e8c3, topicName=MCI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=934111256894, createdName=hukaixun, createdTime=Sat Dec 15 09:04:00 CST 2012, time=2012-12-15, status=1, ipAttribution=)]
    2012-12-15 hukaixun